Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Clinical trial NCT06935994 · RECRUITING

Trial details

NCT number: NCT06935994
Sponsor: Taichung Veterans General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Dysfunction Associated Steatotic Liver Disease

Start date: 2025-05-05
Primary completion: 2028-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.